Production of vaccines – bioprocess development and scale-up

09. juin 2020

In these exceptional and unprecedented times, many companies are working eagerly on the development of a vaccine against COVID-19. New bioprocess technologies, such as single-use equipment and process automation, open up new possibilities for quality control and validation.

This is particularly important in GMP-regulated environments, such as in the development and manufacture of influenza vaccines. When facing a pandemic outbreak, developing new processes and rapidly increasing the volume of clinical production are essential for efficient development of new vaccines.

Date and time: These webinars took place on June 9 and 19, 2020.

Speaker: Marcelo Aguiar Msc., Zone Sales Director, Eppendorf do Brasil Ltda.

Languages: The recorded webinars are only available in Spanish.

Watch here the recordings of the webinars:

Lire moins

Vous vous apprêtez à quitter ce site.

Production of vaccines – bioprocess development and scale-up